The CXCL12-3′ A allele is associated with a higher mobilization yield of CD34 progenitors to the peripheral blood of healthy donors for allogeneic transplantation

Bone Marrow Transplantation

Volumn 44, Issue 5, 2009, Pages 273-278

  Bogunia Kubik, K ^a   Gieryng, A ^a   Dlubek, D ^a,b   Lange, A ^a,b  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b National Bone Marrow Donor Registry   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; PROTEIN MSP 1; RESTRICTION ENDONUCLEASE; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG; CD34 ANTIGEN; CHEMOKINE RECEPTOR CXCR4;

3' UNTRANSLATED REGION; ADOLESCENT; ADULT; AGED; ALLELE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CD34 SELECTION; CHILD; CONTROLLED STUDY; DONOR SELECTION; FEMALE; FLOW CYTOMETRY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LEUKAPHERESIS; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID BASE SUBSTITUTION; PERIPHERAL BLOOD STEM CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX DIFFERENCE; BIOSYNTHESIS; BLOOD DONOR; CYTOLOGY; GENETICS; HEMATOPOIETIC STEM CELL; IMMUNOLOGY; METHODOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; STEM CELL MOBILIZATION;

ADOLESCENT; ADULT; AGED; ALLELES; ANTIGENS, CD34; BLOOD DONORS; CHEMOKINE CXCL12; CHILD; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKAPHERESIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, GENETIC; RECEPTORS, CXCR4; YOUNG ADULT;

EID: 70349116916     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2009.30     Document Type: Article

References (27)

1. Champlin RE, Schmitz N, Horowitz MM, Chapuis B, Chopra R, Cornelissen JJ et al. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation: IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT). Blood 2000; 95: 3702-3709.
2. Dlubek D, Pacuszko T, Suchnicki K, Lange A. G-CSF-mobilized leukapheresis products: Cellular characteristics and clinical performance in allografting. J Hematother 1999; 8: 157-166.
3. Lapidot T, Petit I. Current understanding of stem cell mobilization: The roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol 2002; 30: 973-981.
4. Papayannopoulou T. Current mechanistic scenarios in hematopoietic stem/ progenitor cell mobilization. Blood 2004; 103: 1580-1585.
5. Jankowski K, Kucia M, Wysoczynski M, Reca R, Zhao D, Trzyna E et al Both hepatocyte growth factor (HGF) and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyoscroma cells, but only HGF enhances their resistance to radiochemotherapy. Cancer Res 2003; 63: 7926-7935.
6. Levesque J-P, Bendall LJ, Hendy J, Takamatsu Y, Simmons PJ. Neutrophil enzymes degrade CXC4 on CD34++ progenitors: Implications for progenitor cell mobilization. Blood 2002; 100: 107.
7. Gieryng A, Bogunia-Kubik K. The role of the SDF-1-CXCR4 axis in hematopoiesis and the mobilization of hematopoietic stem cells to peripheral blood. Postepy Hig Med Dosw 2007; 61: 369-383.
8. Burns JM, Summers BC, Wang Y, Melikian A, Berahovich R, Miao Z et al A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med 2006; 203: 2201-2213.
9. Shirozu M, Nakano T, Inazawa J, Tashiro K, Tada H, Shinohara T et al Structure and chromosomal localization of the human stromal cell-derived factor-1 (SDF-1) gene. Genomics 1995; 28: 495-500.
10. Yu L, Cecil J, Peng SB, Schrementi J, Kovacevic S, Paul D et al. Identification and expression of novel isoforms of human stromal cell-derived factor 1. Gene 2006; 374: 174-179.
11. Winkler C, Modi W, Smith MW, Nelson GW, Wu X, Carrington M et al. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. Science 1998; 279: 389-393.
12. Petit I, Szyper-Kravitz M, Nagler A, Lahav M, Peled A, Habler L et al G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 2002; 3: 687-694.
13. Dlubek D, Drabczak-Skrzypek D, Lange A. Low CXCR4 membrane expression on CD34+ cells characterizes cells mobilized to blood. Bone Marrow Transplant 2006; 37: 19-23.
14. Christopherson KW, Cooper S, Broxmeyer HE. Cell surface peptidase CD26/ DPPIV mediates G-CSF mobilization of mouse progenitor cells. Blood 2003; 101: 4680-4686.
15. Benboubker L, Herve W, Carion A, Georget M-M, Desbois I, Colombat P et al. Association between the SDF-1-3′ A allele and high levels of CD34+ progenitor cells mobilized into peripheral blood in humans. Br J Haematol 2001; 113: 247-250.
16. Magierowska M, Lepage V, Boubnova L, Carcassi C, de Juan D, Djoulah S et al. Distribution of the CCR5 gene 32 base pair deletion and SDF1-3′ A variant in healthy individuals from different populations. Immunogenetics 1998; 48: 417-419.
17. Aiuti A, Webb IJ, Bleul C, Springer T, Gutierrez-Ramos JC. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med 1997; 185: 111-120.
18. Hattori K, Heissig B, Tashiro K, Honjo T, Tateno M, Shieh JH et al Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 2001; 97: 3354-3360.
19. Gieryng A, Bogunia-Kubik K, Dlubek D, Duda D, Lange A. The presence of SDF1-3′ A allele is associated with a higher mobilization yield of CD34+ progenitors to peripheral blood in healthy donors of allogeneic HSCT and patients undergoing autologous transplants. Tissue Antigens 2007; 69: S401.
20. Arya SK, Ginsberg CC, Davis-Warren A, D'Costa J. In vitro phenotype of SDF1 gene mutant that delays the onset of human immunodeficiency virus disease in vivo. J Hum Virol 1999; 2: 133-138.
21. Kimura R, Nishioka T, Ishida T. The SDF1-G801A polymorphism is not associated with SDF1 gene expression in Epstein-Barr virus-transformed lymphoblastoid cells. Genes Immun 2003; 4: 356-361.
22. Kimura R, Nishioka T, Soemantri A, Ishida T. Allele-specific transcript quantification detects haplotypic variation in the levels of the SDF-1 transcripts. Hum Mol Genet 2005; 14: 1579-1585.
23. Soriano A, Martinez C, Garcia F, Plana M, Palou E, Lejeune M et al Plasma stromal cell-derived factor (SDF)-1 levels, SDF1-3′ A genotype, and expression of CXCR4 on T lymphocytes: Their impact on resistance to human immunodeficiency virus type 1 infection and its progression. J Infect Dis 2002; 186: 922-931.
24. Signoret N, Oldridge J, Pelchen-Matthews A, Klasse PJ, Tran T, Brass LF et al. Phorbol esters and SDF-1 induce rapid endocytosis and down modulation of the chemokine receptor CXCR4. J Cell Biol 1997; 139: 651-664.
25. Gazitt Y, Liu Q. Plasma levels of SDF-1 and expression of SDF-1 receptor on CD34+ cells in mobilized peripheral blood of non-Hodgkin's lymphoma patients. Stem Cells 2001; 19: 37-45.
26. Carion A, Benboubker L, Herault O, Roingeard F, Degenne M, Senecal D et al. Stromal-derived factor 1 and matrix metalloproteinase 9 levels in bone marrow and peripheral blood of patients mobilized by granulocyte colony-stimulating factor and chemotherapy. Relationship with mobilizing capacity of haematopoietic progenitor cells. Br J Haematol 2003; 122: 918-926.
27. Temple SE, Pham K, Glendenning P, Phillips M, Waterer GW. Endotoxin induced TNF and IL-10 mRNA production is higher in male than female donors: Correlation with elevated expression of TLR4. Cell Immunol 2008; 251: 69-71.